We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare, Inc.’s (HCA - Free Report) third-quarter 2021 adjusted earnings of $4.57 per share beat the Zacks Consensus Estimate of $4.10 by 11.5%. The bottom line also improved 138% year over year on higher revenues.
The company witnessed solid patient volumes in the quarter.
Quarterly Details
HCA Healthcare’s revenues of $15.276 billion beat the Zacks Consensus Estimate by 4.7%. The top line also improved 14.8% from the year-ago period’s figure.
Same facility equivalent admissions increased 9.3% year over year while same facility admissions rose 6.8% year over year. Same facility revenue per equivalent admission grew 5.2% year over year in the quarter.
Same facility inpatient surgeries and same facility outpatient surgeries decreased 4.9% and increased 6.4%, respectively, year over year.
Salaries and benefits, supplies and other operating expenses were up 15.4% year over year.
Adjusted EBITDA totaled $3.2 billion, up 57% year over year.
As of Sep 30, 2021, HCA Healthcare operated 183 hospitals and approximately 2,000 sites of care.
HCA Healthcare, Inc. Price, Consensus and EPS Surprise
Total assets came in at $49.5 billion, up 4.4% from the level at 2020 end.
Total debt less debt issuance costs and discounts of $32 billion increased 4.1% from the level at 2020 end.
In the reported quarter, capex came in at $889 million minus acquisitions.
Cash flows provided by operating activities were $2.277 billion compared with the year-ago period’s figure of $2.717 billion.
2021 Guidance
The company revised its 2021 guidance following solid third-quarter results. Management expects annual revenues in the band of $58.7-$59.3 billion, up from the prior expectation of $57-$58 billion.
Adjusted EBITDA is estimated to be $12.50-$12.80 billion, up from the prior range of $12.10-$12.50 billion.
Capex of the company is still expected at $3.7 billion.
EPS of the company is projected at $17.20-$17.80, up from the previous guidance of $16.30-$17.10 per share.
Share Repurchase and Dividend Update
In the third quarter of 2021, it bought back shares worth $2.329 billion.
HCA Healthcare announced a quarterly cash dividend of 48 cents per share on its common stock. The dividend is payable Dec 29, 2021 to its shareholders of record on Dec 14, 2021.
Of the medical sector players that have reported third-quarter results so far, the bottom-line results of Tenet Healthcare Corporation (THC - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) and Anthem, Inc. beat the respective Zacks Consensus Estimate.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Surge Y/Y
HCA Healthcare, Inc.’s (HCA - Free Report) third-quarter 2021 adjusted earnings of $4.57 per share beat the Zacks Consensus Estimate of $4.10 by 11.5%. The bottom line also improved 138% year over year on higher revenues.
The company witnessed solid patient volumes in the quarter.
Quarterly Details
HCA Healthcare’s revenues of $15.276 billion beat the Zacks Consensus Estimate by 4.7%. The top line also improved 14.8% from the year-ago period’s figure.
Same facility equivalent admissions increased 9.3% year over year while same facility admissions rose 6.8% year over year. Same facility revenue per equivalent admission grew 5.2% year over year in the quarter.
Same facility inpatient surgeries and same facility outpatient surgeries decreased 4.9% and increased 6.4%, respectively, year over year.
Salaries and benefits, supplies and other operating expenses were up 15.4% year over year.
Adjusted EBITDA totaled $3.2 billion, up 57% year over year.
As of Sep 30, 2021, HCA Healthcare operated 183 hospitals and approximately 2,000 sites of care.
HCA Healthcare, Inc. Price, Consensus and EPS Surprise
HCA Healthcare, Inc. price-consensus-eps-surprise-chart | HCA Healthcare, Inc. Quote
Financial Update (as of Sep 30, 2021)
Total assets came in at $49.5 billion, up 4.4% from the level at 2020 end.
Total debt less debt issuance costs and discounts of $32 billion increased 4.1% from the level at 2020 end.
In the reported quarter, capex came in at $889 million minus acquisitions.
Cash flows provided by operating activities were $2.277 billion compared with the year-ago period’s figure of $2.717 billion.
2021 Guidance
The company revised its 2021 guidance following solid third-quarter results.
Management expects annual revenues in the band of $58.7-$59.3 billion, up from the prior expectation of $57-$58 billion.
Adjusted EBITDA is estimated to be $12.50-$12.80 billion, up from the prior range of $12.10-$12.50 billion.
Capex of the company is still expected at $3.7 billion.
EPS of the company is projected at $17.20-$17.80, up from the previous guidance of $16.30-$17.10 per share.
Share Repurchase and Dividend Update
In the third quarter of 2021, it bought back shares worth $2.329 billion.
HCA Healthcare announced a quarterly cash dividend of 48 cents per share on its common stock. The dividend is payable Dec 29, 2021 to its shareholders of record on Dec 14, 2021.
Zacks Rank & Peer Releases
HCA Healthcare currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other Medical Sector Releases
Of the medical sector players that have reported third-quarter results so far, the bottom-line results of Tenet Healthcare Corporation (THC - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) and Anthem, Inc. beat the respective Zacks Consensus Estimate.